Mindstate Design Labs

Mindstate

This pharmaceutical company develops designer psychedelic compounds using artificial intelligence to treat mental health conditions such as treatment-resistant post-traumatic stress disorder.

ATAI

This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.

Psylink

This biotechnology company develops psychedelic therapies using engineered yeast to produce plant and fungi-derived compounds for patients with treatment-resistant mental health disorders.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.

Atai Life Sciences

This biopharmaceutical company develops psychedelic and non-psychedelic therapies for patients living with mental health disorders, including depression, anxiety, and addiction.

Pangea Botanica

This company develops medicines for neurological and mental health disorders using an artificial intelligence platform to discover neuroactive molecules from medicinal plants.

Beckley Psytech

The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.

Mycrodose Therapeutics

This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.